Drug Screening Market Size, Research Report Siemens Healthineers, LabCorp, Thermo Fisher Scientific, Quest Diagnostics, Roche, Abbott, bioMérieux, Bio-Rad Laboratories, Express Diagnostics International, Inc. , Alere Inc.

The Drug Screening market research report offers the crisp and reliable data on Drug Screening market which is useful for organizations to offer solidarity to competitive edge. The report examines the income estimates of all the significant districts and applications. This study additionally contains Drug Screening marketing and value structure concerning value patterns, net margin, factors identified with value change, producers’ net margin analysis, promoting channels. The report further highlights the restraining as well as driving factors which somehow affect the Drug Screening market development rate. It shades light on fundamental winning strategies, approaches and procedures backed by most-powerful players that will help them take crucial business decisions.

The Drug Screening market research report provides an analytical study of influencing factors, prominent industry contenders and regions influencing market. The report additionally demonstrates the strength and weakness of the Drug Screening market players by utilizing SWOT analysis techniques. The report shows the significant framework of existing improvements, points of interest, parameter, and creation. The data incorporated in the report highlights the pros and cons of Drug Screening market and along with the competitive analysis of major companies and key players. The Drug Screening report highlights the alternative products and organizations which can meet the customers’ needs.

Drug screening market is expected to rise gradually to an estimated value of USD 19.03 billion by 2026, registering a CAGR of 12.9% in the forecast period of 2019-2026 with the annual sales of USD 7.21 billion in the year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of people.

Get Free Sample PDF Copy of This Market Information: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-screening-market

Drug screening is used for detecting prescribed as well as illegal drugs in blood, urine, and other biological samples basically at hospitals, places of employment, trained athletes, schools and post-accident. It is considered as a basic part of ongoing diagnosis and treatment, can be by purpose or random. Drug screening takes place at the time of some suspicious cause, generally before employment or sports event. Few of the illegal drugs are cocaine, heroin, amphetamine and cannabis along with which new psychoactive substances (NPS), for instance, ketamine, phenethylamines, and piperazine are rising in the drug market.

According to World Health Organization, there were an estimated 3.3 million people died due to harmful effects of only alcohol, almost more than half of these deaths could have been avoided with the development, organization, monitoring and evaluation of treatment and other services. This significant number is expected to act as a driver to the market growth.

Few of the major competitors currently working in the drug screening market are Siemens Healthcare GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Alere (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Abbott (U.S.),Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France), Express Diagnostics Int’l, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium), CannAmm (Cannada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc.(U.K), Agilent Technologies (U.S), Shimadzu Medical Pvt. Ltd. (Japan) and few among others.

Market Drivers

· Increasing government funding and initiatives for drug testing.

· Rising awareness on drug screening policy

· Growing alcohol and drug abuse in developing countries.

Market Restraints

· In some countries drug testing is considered as a violation of privacy rights.

· Accuracy issues with the breathalyzers.

Get TOC of Full Report: https://databridgemarketresearch.com/toc/?dbmr=global-drug-screening-market

Key Developments in the Market:

· On 6th July, 2017, Endo Pharmaceuticals agreed to remove Opana ER (oxymorphone), its abuse-deterrent extended-release formulation of from the US market a month later the US Food and Drug Administration (FDA) asked the company to stop selling the pain medication.

· On 19th July 2017, Alere Inc., a global leader in rapid diagnostics, announced the availability of Alere iCup , its point-of-care Rx Drug Screen, a rapid urine test that detects five of the most commonly misused and abused prescription drugs which are benzodiazepines, buprenorphine, methadone, opiates and oxycodone. This innovative approach will help the company to generate more revenue.


Segmentation: Global Drug Screening Market

By Product and services

· Equipment

Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Fuel Cell Breathalyzers
Semiconductor Breathalyzers
Other Devices

· Rapid Testing Devices

1. Urine Testing Devices

· Urine Testing Cups

· Dip Cards

· Cassettes

2. Oral Fluid Testing Devices

Consumables

o Assay Kits

o Sample Collection Cups

o Calibrators and Controls

o Others

Laboratory Services

By Sample Type

· Urine

· Breath

· Saliva, Hair

· Blood

· Skin

· Sweat

By End- users

· Workplace and Schools

· Drug Testing Laboratories

· Criminal Justice System & Law Enforcement Agencies

· Hospitals

· Drug Treatment Centers

· Pain Management Centers

· Personal Users

By Geography

· North America

· South America

· Europe

· Asia-Pacific

· Middle East & Africa



Global drug screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug screening market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-screening-market

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.